Search

Your search keyword '"de Weijer, Roel J."' showing total 11 results
Start Over Author "de Weijer, Roel J."
11 results on '"de Weijer, Roel J."'

2. Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial.

Author

Starreveld, Daniëlle EJ, Daniels, Laurien A, Kieffer, Jacobien M, Valdimarsdottir, Heiddis B, de Geus, Jessie, Lanfermeijer, Mirthe, van Someren, Eus JW, Habers, G Esther A, Bosch, Jos A, Janus, Cécile PM, van Spronsen, Dick Johan, de Weijer, Roel J, Marijt, Erik WA, de Jongh, Eva, Zijlstra, Josée M, Böhmer, Lara H, Houmes, Margreet, Kersten, Marie José, Korse, Catharina M, van Rossum, Huub H, Redd, William H, Lutgendorf, Susan K, Ancoli-Israel, Sonia, van Leeuwen, Flora E, and Bleiker, Eveline MA

Subjects
cancer-related fatigue, circadian rhythms, light therapy, randomized controlled trial, sleep, Clinical Research, Depression, Rehabilitation, Rare Diseases, Lymphoma, Cancer, Clinical Trials and Supportive Activities, Behavioral and Social Science, Sleep Research, Hematology, Mental Health, Oncology and Carcinogenesis
Abstract

PurposeTo evaluate the short- and long-term effects of light therapy on fatigue (primary outcome) and sleep quality, depression, anxiety, quality of life, and circadian rhythms (secondary outcomes) in survivors of (non-)Hodgkin lymphoma presenting with chronic cancer-related fatigue.MethodsWe randomly assigned 166 survivors (mean survival 13 years) to a bright white light intervention (BWL) or dim white light comparison (DWL) group. Measurements were completed at baseline (T0), post-intervention (T1), at three (T2), and nine (T3) months follow-up. A mixed-effect modeling approach was used to compare linear and non-linear effects of time between groups.ResultsThere were no significant differences between BWL and DWL in the reduction in fatigue over time. Both BWL and DWL significantly (p < 0.001) improved fatigue levels during the intervention followed by a slight reduction in this effect during follow-up (EST0-T1 = -0.71; EST1-T3 = 0.15). Similar results were found for depression, sleep quality, and some aspects of quality of life. Light therapy had no effect on circadian rhythms.ConclusionsBWL was not superior in reducing fatigue compared to DWL in HL and DLBCL survivors. Remarkably, the total sample showed clinically relevant and persistent improvements on fatigue not commonly seen in longitudinal observational studies in these survivors.

Published
2021

4. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

Author

Neppelenbroek, Suzanne I.M., primary, Geurts, Yvonne M., additional, Aleman, Berthe M.P., additional, Lugtenburg, Pieternella J., additional, Rademakers, Saskia E., additional, de Weijer, Roel J., additional, Schippers, Maaike G.A., additional, Ta, Bastiaan D.P., additional, Plattel, Wouter J., additional, Zijlstra, Josée M., additional, van der Maazen, Richard W.M., additional, Nijziel, Marten R., additional, Ong, Francisca, additional, Schimmel, Erik C., additional, Posthuma, Eduardus F.M., additional, Kersten, Marie José, additional, Böhmer, Lara H., additional, Muller, Karin, additional, Koene, Harry R., additional, te Boome, Liane C.J., additional, Bilgin, Yavuz M., additional, de Jongh, Eva, additional, Janus, Cécile P.M., additional, van Leeuwen, Flora E., additional, and Schaapveld, Michael, additional

Published
2024
Full Text
View/download PDF

7. T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors

Author

Neppelenbroek, Suzanne I.M., primary, Geurts, Yvonne M.G., additional, Aleman, Berthe M. P., additional, Janus, Cécile P.M., additional, Lugtenburg, Pieternella J., additional, Rademaker, Saskia E., additional, De Weijer, Roel J., additional, Schippers, Maaike G.A., additional, Ta, Bastiaan D.P., additional, Plattel, Wouter J., additional, Zijlstra, Josée. M., additional, Van Der Maazen, Richard W.M., additional, Nijziel, Marten R., additional, Ong, Francisca, additional, Schimmel, Erik C., additional, Posthuma, Eduardus F.M., additional, Kersten, Marie José, additional, Böhmer, Lara H., additional, Muller, Karin, additional, Koene, Harry R., additional, Te Boome, Liane C.J., additional, Bilgin, Yavuz M., additional, De Jongh, Eva, additional, Van Leeuwen, Flora E., additional, and Schaapveld, Michael, additional

Published
2022
Full Text
View/download PDF

8. Treatment-specific risk of second malignancies in five-year survivors of diffuse large B-cell lymphoma.

Author

Geurts, Yvonne M., primary, Neppelenbroek, Suzanne I.M., additional, So-Osman, Cynthia, additional, Vermaat, Joost S.P., additional, van Spronsen, Dick Johan, additional, Plattel, Wouter J., additional, de Weijer, Roel J., additional, Verschueren, Karijn M.S., additional, Zijlstra, Josée M., additional, Koene, Harry R., additional, Nijziel, Marten R., additional, Schimmel, Erik C., additional, Böhmer, Lara H., additional, Ong, Francisca, additional, Visser, Hein, additional, van Kampen, Daphne, additional, Kersten, Marie José, additional, Aleman, Berthe M.P., additional, Van Leeuwen, Flora, additional, and Schaapveld, Michael, additional

Published
2021
Full Text
View/download PDF

9. Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors.

Author

Neppelenbroek, Suzanne I.M., primary, Geurts, Yvonne M., additional, Aleman, Berthe M.P., additional, Janus, Cecile P.M., additional, Rademakers, Saskia E, additional, de Weijer, Roel J., additional, Van Der Maazen, Richard W.M., additional, Zijlstra, Josée M., additional, Beijert, Max, additional, Verschueren, Karijn M.S., additional, Ta, Bastiaan, additional, Nijziel, Marten R., additional, Posthuma, Eduardus F.M., additional, Kersten, Marie José, additional, Muller, Karin, additional, te Boome, Liane, additional, Bilgin, Yavuz, additional, de Jongh, Eva, additional, Schaapveld, Michael, additional, and Van Leeuwen, Flora, additional

Published
2021
Full Text
View/download PDF

10. Attendance to Hodgkin lymphoma survivorship care clinics in the Netherlands.

Author

Nijdam, Annelies, primary, de Weijer, Roel J., additional, Janus, Cecile P.M., additional, Clevers-Petersen, Eefke J., additional, Roesink, Judith M., additional, Lugtenburg, Pieternella J., additional, van 't Veer, Mars B., additional, Aleman, Berthe M.P., additional, Raemaekers, John M. M., additional, and Van Leeuwen, Flora, additional

Published
2017
Full Text
View/download PDF

11. Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma.

Author

Nijdam A, Dekker N, Aleman BMP, van 't Veer MB, Daniels LA, van der Maazen RW, Janus CPM, de Weijer RJ, Zijlstra JM, Stedema FG, Ta BD, Posthuma EFM, Manenschijn A, Dielwart MFH, Bilgin YM, van den Heuvel MJ, Boersma RS, van Leeuwen FE, and Raemaekers JMM

Subjects
Hodgkin Disease therapy, Humans, Netherlands epidemiology, Registries, Cancer Survivors, Continuity of Patient Care, Hodgkin Disease epidemiology, National Health Programs, Survivorship
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results